Namita Thapar's Emcure Pharma Made Remarkable Debut On D-Street | Find Out The Key Details | ET Now

The Emcure Pharma IPO has made a remarkable debut in the stock market, listing at a significant premium of 30%. This successful initial public offering has garnered attention from investors and industry experts alike. In an exclusive interview, Namita Thapar and Satish Mehta share insightful details about the IPO. This news update provides valuable information for individuals interested in the business world, particularly in the pharmaceutical sector.

#emcurepharma #emcurepharmaipo #ipolauch #etnow #unionbudget2024 #budget2024 #topnews #stockmarket #businessnews #sharemarketnews

Subscribe To ET Now For Latest Updates On Stocks, share market, business News, Trading, Crypto Updates | https://bit.ly/SubscribeToETNow

To Stay Updated Download the Times Now App :-
Android Google Play : https://goo.gl/zJhWjC
Apple App Store : https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Subscribe Now To Our Network Channels:-
Times Now: https://bit.ly/SubscribeToTimesNow
Mirror Now: https://bit.ly/SubscribeToMirrorNow